Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Wholesalers also affected by pregabalin ‘market shock’

Wholesalers as well as pharmacists are “losing out” as the market adjusts to pregabalin moving to category M, the Healthcare Distribution Association (HDA) has told C+D.

Pregabalin entered category M in August, two months after NHS England announced the drug should be prescribed “in accordance with normal practice”.

Pregabalin prices in the drug tariff currently range from £1.87 for a pack of 56 25mg capsules to £4.17 for a pack of 56 300mg capsules. But contractors told C+D last week they are being forced to pay almost £20 per pack by wholesalers.

Responding to C+D’s coverage, HDA executive director Martin Sawer said: “It seems that the market shocks flowing from such a large price drop for such a big volume product have been playing out.”

“Not only will pharmacists be losing out in the short term, but so will wholesalers, as the market adjusts.”

“All players in the supply chain have a duty to avoid supply shortages,” he added.

Mr Sawer was commenting in response to the Pharmaceutical Services Negotiating Committee’s call for contractors to exert “maximum pressure” on wholesalers to match the reduction in pregabalin’s reimbursement price.

Numark also told C+D last week that price hikes are "are not unusual with molecules where there is sometimes a shortage in the market – wholesalers have to pay more for a limited amount of stock”.

Have you noticed an increase in pregabalin prices?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel